BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31230567)

  • 1. Polygenic risk-stratified screening for cancer: Responsibilization in public health genomics.
    Kerr A; Broer T; Ross E; Cunningham Burley S
    Soc Stud Sci; 2019 Aug; 49(4):605-626. PubMed ID: 31230567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health genomics and personalized prevention: lessons from the COGS project.
    Pashayan N; Hall A; Chowdhury S; Dent T; Pharoah PD; Burton H
    J Intern Med; 2013 Nov; 274(5):451-6. PubMed ID: 24127941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing the public in public perceptions research: A case study of forest genomics.
    Berseth V; Taylor J; Hutchen J; Nguyen V; Schott S; Klenk N
    Public Underst Sci; 2024 May; 33(4):483-503. PubMed ID: 38095191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can polygenic inheritance be used in population screening for common diseases?
    Khoury MJ; Janssens AC; Ransohoff DF
    Genet Med; 2013 Jun; 15(6):437-43. PubMed ID: 23412608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australia: public health genomics.
    Metcalfe SA; Bittles AH; O'Leary P; Emery J
    Public Health Genomics; 2009; 12(2):121-8. PubMed ID: 19039256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Views of the Australian public on the delivery of risk-stratified cancer screening in the population: a qualitative study.
    Dunlop K; Rankin NM; Smit AK; Newson AJ; Keogh LA; Cust AE
    Public Health Res Pract; 2023 Jul; 33(2):. PubMed ID: 36065020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the role of society and risk in xenotransplantation.
    Sobbrio P; Jorqui M
    Xenotransplantation; 2014; 21(6):523-32. PubMed ID: 25040770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study.
    Vermeulen E; Henneman L; van El CG; Cornel MC
    Eur J Public Health; 2014 Oct; 24(5):768-75. PubMed ID: 24068545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placing Publics in Public Health Genomics.
    Fox BM; Martschenko DO
    Public Health Genomics; 2024; 27(1):23-29. PubMed ID: 38128495
    [No Abstract]   [Full Text] [Related]  

  • 10. Engaged genomic science produces better and fairer outcomes: an engagement framework for engaging and involving participants, patients and publics in genomics research and healthcare implementation.
    Murtagh MJ; Machirori M; Gaff CL; Blell MT; de Vries J; Doerr M; Dove ES; Duncanson A; Hastings Ward J; Hendricks-Sturrup R; Ho CWL; Johns A; Joly Y; Kato K; Katsui K; Kumuthini J; Maleady-Crowe F; Middleton A; Milne R; Minion JT; Matshaba M; Mulrine S; Patch C; Ryan R; Viney W
    Wellcome Open Res; 2021; 6():311. PubMed ID: 35592835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.
    Nicholls SG; Etchegary H; Carroll JC; Castle D; Lemyre L; Potter BK; Craigie S; Wilson BJ;
    BMC Med Genomics; 2016 May; 9(1):25. PubMed ID: 27215612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publics' knowledge of, attitude to and motivation towards health-related genomics: a scoping review.
    Pearce A; Mitchell LA; Best S; Young MA; Terrill B
    Eur J Hum Genet; 2024 Feb; ():. PubMed ID: 38316954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
    Meisel SF; Rahman B; Side L; Fraser L; Gessler S; Lanceley A; Wardle J;
    BMC Womens Health; 2016 Jul; 16():46. PubMed ID: 27460568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing public health genomics in Africa through prospective cohort studies.
    Dalal S; Holmes MD; Ramesar RS
    J Epidemiol Community Health; 2010 Jul; 64(7):585-6. PubMed ID: 20547699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy.
    Marzuillo C; De Vito C; D'Addario M; Santini P; D'Andrea E; Boccia A; Villari P
    BMC Health Serv Res; 2014 May; 14():239. PubMed ID: 24885316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive genetic testing for complex diseases: a public health perspective.
    Marzuillo C; De Vito C; D'Andrea E; Rosso A; Villari P
    QJM; 2014 Feb; 107(2):93-7. PubMed ID: 24049051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public.
    Dunlop K; Rankin NM; Smit AK; Salgado Z; Newson AJ; Keogh L; Cust AE
    Health Expect; 2021 Aug; 24(4):1326-1336. PubMed ID: 33974726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecuador: public health genomics.
    González-Andrade F; López-Pulles R
    Public Health Genomics; 2010; 13(3):171-80. PubMed ID: 19844075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the Scope of Public Engagement: Examining the "Right Not to Know" in Public Health Genomics.
    Allen C; Sénécal K; Avard D
    J Law Med Ethics; 2014; 42(1):11-8. PubMed ID: 26767472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRSet: Pathway-based polygenic risk score analyses and software.
    Choi SW; García-González J; Ruan Y; Wu HM; Porras C; Johnson J; ; Hoggart CJ; O'Reilly PF
    PLoS Genet; 2023 Feb; 19(2):e1010624. PubMed ID: 36749789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.